ACADIA Pharmaceuticals
ACAD
#3726
Rank
A$5.31 B
Marketcap
A$30.77
Share price
0.07%
Change (1 day)
-9.93%
Change (1 year)

ACADIA Pharmaceuticals (ACAD) - Total debt

Total debt on the balance sheet as of June 2026 : A$0.10 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's total debt is A$0.10 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

ACADIA Pharmaceuticals - Total debt on balance sheet (from 2003 to 2026)

Total debt by year

Year Total debt Change
2025-12-31A$77.91 M-6.79%
2024-12-31A$83.59 M-0.44%
2023-12-31A$83.96 M-7.84%
2022-12-31A$91.1 M2.52%
2021-12-31A$88.87 M37.92%
2020-12-31A$64.43 M360.59%
2019-12-31A$13.99 M
2018-12-31N/A
2011-12-31A$0.03 M-71.18%
2010-12-31A$0.1 M-78.99%
2009-12-31A$0.51 M-70.32%
2008-12-31A$1.73 M-28.86%
2007-12-31A$2.44 M-18.98%
2006-12-31A$3.01 M23.71%
2005-12-31A$2.43 M-25.51%
2004-12-31A$3.26 M-50.06%
2003-12-31A$6.54 M-42.67%
2002-12-31A$11.41 M340.53%
2001-12-31A$2.59 M-74.96%
2000-12-31A$10.35 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
A$64.67 B 60,358.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$91.53 B 85,466.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$71.70 B 66,928.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$64.90 B 60,573.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
A$33.06 M-69.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA